Eisfeld C, Reichelt D, Evers S, Husstedt I
CNS Drugs. 2012; 27(1):31-55.
PMID: 23160938
DOI: 10.1007/s40263-012-0018-x.
Mueller B, Lewis L, Yuen G, Farley M, Keller A, Church J
Antimicrob Agents Chemother. 1998; 42(12):3187-92.
PMID: 9835513
PMC: 106021.
DOI: 10.1128/AAC.42.12.3187.
Borg N, Stahle L
Antimicrob Agents Chemother. 1998; 42(9):2174-7.
PMID: 9736530
PMC: 105766.
DOI: 10.1128/AAC.42.9.2174.
Mueller B, Anderson B, Farley M, Murphy R, Zuckerman J, Jarosinski P
Antimicrob Agents Chemother. 1998; 42(7):1815-8.
PMID: 9661027
PMC: 105689.
DOI: 10.1128/AAC.42.7.1815.
Daluge S, Good S, Faletto M, Miller W, St Clair M, BOONE L
Antimicrob Agents Chemother. 1997; 41(5):1082-93.
PMID: 9145874
PMC: 163855.
DOI: 10.1128/AAC.41.5.1082.
Pharmacokinetics of (-)-beta-D-2-aminopurine dioxolane and (-)-beta-D-2-amino-6-chloropurine dioxolane and their antiviral metabolite (-)-beta-D-dioxolane guanine in rhesus monkeys.
Chen H, Boudinot F, Chu C, McClure H, Schinazi R
Antimicrob Agents Chemother. 1996; 40(10):2332-6.
PMID: 8891140
PMC: 163530.
DOI: 10.1128/AAC.40.10.2332.
Pharmacokinetics of lamivudine and BCH-189 in plasma and cerebrospinal fluid of nonhuman primates.
Blaney S, Daniel M, Harker A, Godwin K, Balis F
Antimicrob Agents Chemother. 1995; 39(12):2779-82.
PMID: 8593019
PMC: 163029.
DOI: 10.1128/AAC.39.12.2779.
Efflux of zidovudine and 2',3'-dideoxyinosine out of the cerebrospinal fluid when administered alone and in combination to Macaca nemestrina.
Tuntland T, Ravasco R, Unadkat J
Pharm Res. 1994; 11(2):312-7.
PMID: 8165194
DOI: 10.1023/a:1018928013044.
Clinical pharmacology of zidovudine and other 2',3'-dideoxynucleoside analogues.
Kamali F
Clin Investig. 1993; 71(5):392-405.
PMID: 7685214
DOI: 10.1007/BF00186630.
Pharmacokinetics of dideoxypurine nucleoside analogs in plasma and cerebrospinal fluid of rhesus monkeys.
Hawkins M, Mitsuya H, McCully C, Godwin K, Murakami K, Poplack D
Antimicrob Agents Chemother. 1995; 39(6):1259-64.
PMID: 7574512
PMC: 162723.
DOI: 10.1128/AAC.39.6.1259.
Enhanced oral bioavailability of DDI after administration of 6-Cl-ddP, an adenosine deaminase-activated prodrug, to chronically catheterized rats.
Anderson B, Morgan M, Singhal D
Pharm Res. 1995; 12(8):1126-33.
PMID: 7494823
DOI: 10.1023/a:1016299507382.
Clinical pharmacokinetics of zidovudine. An overview of current data.
Collins J, Unadkat J
Clin Pharmacokinet. 1989; 17(1):1-9.
PMID: 2663302
DOI: 10.2165/00003088-198917010-00001.
Zidovudine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
Langtry H
Drugs. 1989; 37(4):408-50.
PMID: 2661194
DOI: 10.2165/00003495-198937040-00003.
Pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-deoxy-2',3'-didehydrothymidine in rhesus monkeys.
Schinazi R, Boudinot F, Doshi K, McClure H
Antimicrob Agents Chemother. 1990; 34(6):1214-9.
PMID: 2168144
PMC: 171787.
DOI: 10.1128/AAC.34.6.1214.
Pharmacokinetics of 3'-azido-3'-deoxythymidine and its catabolites and interactions with probenecid in rhesus monkeys.
Cretton E, Schinazi R, McClure H, Anderson D, Sommadossi J
Antimicrob Agents Chemother. 1991; 35(5):801-7.
PMID: 1854160
PMC: 245110.
DOI: 10.1128/AAC.35.5.801.
Analysis of zidovudine distribution to specific regions in rabbit brain using microdialysis.
Wong S, Wang Y, Sawchuk R
Pharm Res. 1992; 9(3):332-8.
PMID: 1614966
DOI: 10.1023/a:1015834701136.
Penetration of zidovudine and 3'-fluoro-3'-deoxythymidine into the brain, muscle tissue, and veins in cynomolgus monkeys: relation to antiviral action.
Guzenda E, Bottiger D, Wahren B, Oberg B, Stahle L
Antimicrob Agents Chemother. 1992; 36(11):2418-22.
PMID: 1489185
PMC: 284346.
DOI: 10.1128/AAC.36.11.2418.
Central nervous system targeting of 2',3'-dideoxyinosine via adenosine deaminase-activated 6-halo-dideoxypurine prodrugs.
Morgan M, Chi S, Murakami K, Mitsuya H, Anderson B
Antimicrob Agents Chemother. 1992; 36(10):2156-65.
PMID: 1444295
PMC: 245470.
DOI: 10.1128/AAC.36.10.2156.
Pharmacokinetics and metabolism of racemic 2',3'-dideoxy-5-fluoro-3'-thiacytidine in rhesus monkeys.
Schinazi R, Boudinot F, Ibrahim S, Manning C, McClure H, Liotta D
Antimicrob Agents Chemother. 1992; 36(11):2432-8.
PMID: 1336946
PMC: 284348.
DOI: 10.1128/AAC.36.11.2432.
Zalcitabine. A review of its pharmacology and clinical potential in acquired immunodeficiency syndrome (AIDS).
Whittington R, Brogden R
Drugs. 1992; 44(4):656-83.
PMID: 1281077
DOI: 10.2165/00003495-199244040-00009.